ArticleThe Journal of clinical investigation2022

HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy.

Shaima Salman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.